The Ahmed ClearPath glaucoma drainage device has been commercially launched in the United States. Available in 350 mm2 and 250 mm2 sizes, the implant includes a flexible plate with a contour that conforms to the curvature of the eye and suture fixation points positioned more anteriorly on the device in comparison to other valveless drainage devices. It is designed to address tube shunt surgery challenges and comes with an optional pre-threaded ripcord and a 23-gauge needle. One feature of the Ahmed ClearPath implant is a flexible plate with a contour that closely conforms to the curvature of the eye. In addition, the suture fixation points are positioned more anteriorly on the device compared to other valveless drainage devices. By making the suture points more visible and accessible, the company said the surgeon may find securing this implant to the eye more convenient. The device or procedures are reserved for mild to moderate glaucoma cases.
Kauvery Hospital, a multi-speciality and tertiary care hospital chain, will provide comprehensive and advanced neuro and spine treatment using 3D and robotic technology.
For a long time, cancer has been treated with conventional open surgery that left patients with pain and prolonged recovery. However, the advent of robotics has completely transformed this space. - Dr Sandeep Nayak
Transasia Bio-Medicals Ltd., recently announced a Rs 50 crore investment in the expansion of its manufacturing facility in Sikkim.
Innovative Financial Advisors Pvt. Ltd (Fiinovation) recently partnered with Himachal Futuristic Communications (HFCL) for evaluation of HFCL’s Mobile Medical Units (MMU) projects running in Goa, Solan - Himachal Pradesh, Ghazipur - Uttar Pradesh and Sardarshahar – Rajasthan.